Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velphoro vs Sevelamer Carbonate in Chinese CKD Patients with Hyperphosphataemia
NCT03644264Phase 3Completed
- Sponsor
- CSL Vifor
- Start
- Aug 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of iron sucrose in hyperphosphatemia, sponsored by CSL Vifor. Started Aug 2018; status: completed.
02
Drugs
iron sucrose
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT03644264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03644264.